The incidence of food-based anaphylaxis is increasing, especially among children. Studies suggest this may be due to growing variety in the American diet, which may expose children to more foods containing nut proteins—a common allergen.
The Food Allergy and Anaphylaxis Network offers the following advice regarding peanut and tree nut allergies:
- Strict avoidance of the allergy-causing food is the only way to avoid a reaction. Reading ingredient labels for all foods is the key to maintaining control over the allergy. If a product doesn't have a label, allergic individuals should not eat that food. If a label contains unfamiliar terms, shoppers must call the manufacturer and ask for a definition or avoid eating that food.
- Many nut butters are produced on equipment used to process peanut butter, therefore making it somewhat of a risky alternative.
- Kick sacks, hacky sacks, and bean bags are sometimes filled with crushed nut shells.
- Bring a "safe" dish with you when visiting a friend or a relative; he or she will appreciate it, and you'll rest easier, too.
- Ask about ingredients and cooking methods used whether you are in a restaurant, friend's home, or about to serve a dish someone brought to your home.
In addition, Twinject reminds you to:
- Inform your employer, school, college, or child's playgroup about your or your child's allergy to ensure a safe work, study, or play environment.
- Don't be shy about reminding food service and childcare workers about your or your child's food allergy during each visit. It's better to be safe than sorry!
- Print and use the Chef's Food Allergy Alert Card when eating meals away from home.
- Remember to carry your Twinject with you at all times.
For more information about food allergies, visit www.foodallergy.org.
IMPORTANT SAFETY INFORMATION ABOUT TWINJECT: Twinject is indicated in the emergency treatment of severe allergic reaction (type I) including anaphylaxis to stinging insects and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as anaphylaxis to unknown substance or exercise-induced anaphylaxis.
Since the dose of epinephrine delivered from Twinject 0.15 mg is fixed at 0.15 mg, the physician should consider other forms of injectable epinephrine if doses lower than 0.15 mg are felt to be necessary (eg, patients who weigh less than 15 kilograms [approximately 33 pounds]).
Twinject should only be injected into the anterolateral aspect of the thigh. Accidental injection into the hands or feet may result in loss of blood flow to the affected area and should be avoided. DO NOT INJECT INTO BUTTOCK. DO NOT INJECT INTRAVENOUSLY.
Epinephrine should be administered with caution to patients with cardiac arrhythmias, coronary artery or organic heart disease, or hypertension. In patients with coronary insufficiency or ischemic heart disease, epinephrine may precipitate or aggravate angina pectoris as well as produce ventricular arrhythmias. It should be recognized that the presence of these conditions is not a contraindication to epinephrine administration in an acute life-threatening situation. Adverse reactions to epinephrine include transient, moderate anxiety; apprehensiveness; restlessness; tremor; weakness; dizziness; sweating; palpitations; pallor; nausea and vomiting; headache; and/or respiratory difficulties.
Twinject is designed as an emergency supportive therapy only and is not a replacement or substitute for immediate medical care.